Research by Joel Cantor et al. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study”

April 17, 2023

Abstract

Despite effective antiviral therapy for hepatitis C virus (HCV), people who are incarcerated and those returning to the community face challenges in obtaining HCV treatment. We aimed to explore facilitators and barriers to HCV treatment during and after incarceration. From July–November 2020 and June–July 2021, we conducted 27 semi-structured interviews with residents who were formerly incarcerated in jail or prison. The interviews were audio-recorded and professionally transcribed. We used descriptive statistics to characterize the study sample and analyzed qualitative data thematically using an iterative process. Participants included five women and 22 men who self-identified as White (n = 14), Latinx (n = 8), and Black (n = 5). During incarceration, a key facilitator was having sufficient time to complete HCV treatment, and the corresponding barrier was delaying treatment initiation. After incarceration, a key facilitator was connecting with reentry programs (e.g., halfway house or rehabilitation program) that coordinated the treatment logistics and provided support with culturally sensitive staff. Barriers included a lack of insurance coverage and higher-ranking priorities (e.g., managing more immediate reentry challenges such as other comorbidities, employment, housing, and legal issues), low perceived risk of harm related to HCV, and active substance use. Incarceration and reentry pose distinct facilitators and challenges to accessing HCV treatment. These findings signal the need for interventions to improve engagement in HCV care both during and after incarceration to assist in closing the gap of untreated people living with HCV.

Keywords: HCV; Hepatitis C; treatment; direct-acting antiviral DAA; prison; jail; incarceration; linkage to care; qualitative

Citation

Kamat, Samir, Sankeerth Kondapalli, Shumayl Syed, Gabrielle Price, George Danias, Ksenia Gorbenko, Joel Cantor, Pamela Valera, Aakash K. Shah, and Matthew J. Akiyama. 2023. “Access to Hepatitis C Treatment during and after Incarceration in New Jersey, United States: A Qualitative Study” Life 13, no. 4: 1033. https://doi.org/10.3390/life13041033

Recent Posts

Dan Kennedy (MCRP ’07): CRE Roadmap for Next Governor

As New Jersey prepares to elect its next governor, NAIOP NJ, the commercial real estate development association, has published a comprehensive roadmap for economic revitalization and sustainable development for the consideration of both candidates for governor. As a...

“Work Trends RU” Podcast with WorkingNation’s Jane Oates

This week's guest on the Heldrich Center's Work Trends RU podcast is Jane Oates, Senior Policy Advisor at WorkingNation. She and Dr. Carl Van Horn discuss WorkingNation’s mission, objectives, and accomplishments; the power of digital storytelling; the challenges of...

Zhang et al. Study Street-View Greenspace and Exercise

GPS-based street-view greenspace exposure and wearable assessed physical activity in a prospective cohort of US women Abstract Background Increasing evidence positively links greenspace and physical activity (PA). However, most studies use measures of greenspace, such...

NJSPL: Some College, No Credential Population in NJ

Overview of the Some College, No Credential Population and Educational Outcomes in New Jersey, 2023–2024 New Jersey State Policy Lab Supporting New Jersey residents in returning to college after leaving without a credential has been an increasing focus of the state’s...

Loh and Noland Explore Public Charging Station Disparities

Equal charging for all: Are there income-based disparities in public charging stations? Abstract We compare charging station accessibility for different income groups in the San Francisco Bay Area. Using a microsimulation model, we estimate charging station...